Previous Article | Next Article 
Journal of Clinical Microbiology, May 2000, p. 2010-2014, Vol. 38, No. 5
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Bilateral Pulmonary Aspergilloma Caused by an
Atypical Isolate of Aspergillus terreus
Z. U.
Khan,1,*
M.
Kortom,2
R.
Marouf,3
R.
Chandy,1
M. G.
Rinaldi,4,5 and
D. A.
Sutton4
Department of Microbiology, Faculty of Medicine, Kuwait
University,1 and Departments of
Medicine2 and
Hematology,3 Mubarak Al-Kabeer Hospital,
Ministry of Public Health, Kuwait, and Fungus Testing
Laboratory, Department of Pathology, University of Texas Health
Science Center at San Antonio,4 and
Audie L. Murphy Division, South Texas Veterans Health Care
System,5 San Antonio, Texas 78284
Received 24 September 1999/Returned for modification 26 November
1999/Accepted 13 February 2000
 |
ABSTRACT |
A case of bilateral pulmonary aspergilloma caused by an atypical
isolate of Aspergillus terreus is described. The diagnosis was established by the presence of septate, dichotomously branched fungal elements in freshly collected bronchoalveolar lavage and sputum
specimens and by repeated isolation of the fungus in culture. Specific
precipitating antibodies against the A. terreus isolate were demonstrated in the patient's serum. The isolate was atypical as
it failed to produce fruiting structures on routine mycological media,
but it did so on extended incubation on potato flake agar and produced
globose, relatively heavy-walled, hyaline accessory conidia (formerly
termed aleurioconidia) on both vegetative and aerial mycelia. Also, it
produced an intense yellow diffusing pigment in the medium. The report
underscores the increasing importance of A. terreus in the
etiology of pulmonary aspergillosis. It is suggested that A. terreus antigen be included in the battery of serodiagnostic
reagents to facilitate the early diagnosis of infections caused by this species.
 |
CASE REPORT |
A 26-year-old Syrian male who was known to have type I
(insulin-dependent) diabetes mellitus was admitted to Mubarak
Al-Kabeer Hospital in Kuwait in November 1996. He complained of general fatigue, tiredness, a productive cough, especially at
night, and numbness in his fingertips and toes. He had
lost 20 kg of weight during the previous year. The patient gave a
history of pulmonary tuberculosis in his country of origin 4 years
earlier, for which he received treatment for 6 months. On physical
examination, the patient was conscious and fully alert. His temperature
was 36.9°C, his pulse was 80 beats/min, and his blood pressure was
120/80 mmHg. He had no lymphadenopathy. There was clubbing of his
fingers and toes. Examination of the chest revealed the presence of a pleural rub and anterior and posterior bilateral basal crepitations. Examination of the heart and abdomen revealed no abnormality. Central
nervous system examination showed evidence of polyneuropathy of the
gloves-and-stocking pattern. Nerve conduction studies of both the hands
and feet showed the presence of moderately severe axonal peripheral
neuropathy secondary to diabetes. Laboratory investigations showed
markedly raised blood sugar levels (21 mmol/liter) with normal renal
function. His white blood cell count was 10.8 × 10/liter with
61% neutrophils. Examination of the urine showed high levels of
glucose (56 mmol/liter), but no protein or red blood cells were
observed. A chest X ray and a computed tomography (CT) scan showed the
presence of a "fungal ball" in the right and left apical regions
(Fig. 1 and
2). It also showed in the upper zones the
presence of fibronodular infiltrations, which were probably due to the
old tubercular infection. Pulmonary function tests showed an
obstructive pattern which improved with bronchodilators and a decreased
total lung capacity which suggested a restrictive pattern. Microscopic
examination of bronchoalveolar lavage specimens showed many pus cells,
a number of fungal elements, gram-positive cocci, and gram-negative
bacilli. A potassium hydroxide-calcofluor mount confirmed the presence
of septate, dichotomously branched hyphae (Fig.
3). Culture yielded Haemophilus
influenzae, beta-hemolytic streptococci, and Streptococcus
pneumoniae and many colonies of a mold. Repeat culture of sputum
specimens yielded the same fungus. Since the conidial heads were not
observed on the initial examination of the fungal isolate, it was
provisionally identified as a Scedosporium species due to
the presence of thick-walled, single-celled conidia that arose directly
from the hyphae or that developed at the tip of the conidiogenous cells
and that were mistaken for annelloconidia. The isolate was later
confirmed to be an atypical strain of Aspergillus terreus.
The patient's serum was tested for precipitins against Aspergillus (poly) antigen (Meridian Diagnostics, Inc.,
Cincinnati, Ohio) and against culture filtrate antigens of
Aspergillus fumigatus and Aspergillus flavus
prepared in our laboratory (11), but it was found to be
negative. However, when culture filtrate and mycelial antigens prepared
from the patient's isolate were used, 3 and 1 precipitin lines,
respectively, were obtained in an immunodiffusion test (Fig.
4). The culture filtrate antigen was
prepared by growing the isolate in glucose asparagine broth as a
stationary culture at 28°C for 3 weeks (11). The filtrate
was dialyzed and concentrated 15 times by evaporation. The mycelial
antigen was prepared by grinding 10 g of the separated mycelial
mat in 20 ml of phosphate-buffered saline (0.05 M; pH 7.4) with glass
beads in a pestle and mortar. The slurry so obtained was centrifuged at
15,000 × g for 15 min. The supernatant was filtered
through a Nalgene filter unit (pore size, 0.45 µm), dialyzed, and
concentrated about 10 times for use as an antigen. Since the patient
had a chest infection, he was treated with ampicillin at 1 g every
6 h and cefotaxime at 1 g every 8 h. His diabetes was
controlled with higher doses of insulin until a satisfactory level of
blood sugar was achieved. He was discharged after 1 week of
antibacterial therapy. No surgical intervention or specific antifungal
therapy was planned since he had no hemoptysis or other
aspergilloma-associated symptoms. The patient has since been lost for
follow-up.

View larger version (126K):
[in this window]
[in a new window]
|
FIG. 1.
Posterioanterior chest radiograph showing cavitary
lesions in both the lung fields with aspergilloma in the right upper
zone (arrow).
|
|

View larger version (110K):
[in this window]
[in a new window]
|
FIG. 3.
Potassium hydroxide-calcofluor mount showing septate,
dichotomously branched hyphae of A. terreus in
bronchoalveolar lavage sediment. Magnification, ×400.
|
|

View larger version (118K):
[in this window]
[in a new window]
|
FIG. 4.
Ouchterlony's double diffusion test. The central well
(G) contained the patient's serum, and peripheral wells contained
culture filtrate (A) and mycelial antigens (B, C, and D) prepared from
the A. terreus isolate. Peripheral wells contained culture
filtrate antigens of A. fumigatus and A. flavus
(E and F, respectively). Note the precipitin bands against A. terreus antigens.
|
|
Aspergillus species are widely distributed in the
environment, and infection is acquired primarily through the
respiratory tract (19). Although over 200 different species
of Aspergillus are known, only a few are recognized human
pathogens (3). A. fumigatus and A. flavus are the most frequent etiologic agents of pulmonary and
systemic aspergillosis, whereas infection with A. terreus is
rarely reported (3). So far, A. terreus has been incriminated as a causative agent in allergic bronchopulmonary aspergillosis (12, 13), invasive aspergillosis (4, 9, 10, 30), cardiac infections (6, 22, 23), osteomyelitis (25), and septic arthritis (27). Cases of
pulmonary aspergilloma due to A. terreus have rarely been
reported (12). Here, we describe a case of bilateral
pulmonary aspergilloma in a 26-year-old diabetic patient caused by an
atypical strain of A. terreus.
Description of isolate.
The isolate was moderately fast
growing on Sabouraud dextrose agar (Difco Laboratory, Detroit, Mich.),
attaining a diameter of 60 mm in 10 days at 28°C with entire margins.
The color was variable in shades of yellow but became salmon to
cinnamon colored on aging and produced diffusible pigment. The isolate
was able to grow on Mycobiotic agar (containing chloramphenicol and
cycloheximide; Difco Laboratories) at 37°C reaching a diameter of 50 mm in 7 days (Fig. 5). Microscopically,
hyphae were septate and hyaline, producing smooth, thick-walled,
spherical to pear-shaped accessory conidia (formerly referred to as
aleurioconidia), which mostly occurred singly and which measured 3 to 5 µm in diameter (Fig. 6). The isolate
failed to produce fruiting structures on Sabouraud dextrose agar,
Czapek agar, and malt yeast extract agar. The isolate was forwarded to
the Fungus Testing Laboratory, Department of Pathology, University of
Texas Health Science Center (UTHSC) at San Antonio, for further
characterization and was accessioned into the stock collection as
strain UTHSC 98-403. There the isolate was subcultured onto potato
flake agar (PFA) prepared in-house and was incubated at 25°C
(20). The isolate grew rapidly, producing deep orange
colonies that had a lemon yellow diffusing pigment and that were
similar to those produced on Sabouraud dextrose agar. A slide culture
prepared on PFA produced the thick-walled globose cells but failed to
produce diagnostic fruiting structures. After 10 weeks of incubation,
stereoscopic examination of the colonies revealed small, strongly
columnar fruiting structures consistent with an Aspergillus
species. The microscopic morphology of these structures, when examined
by tape mounts, revealed globose vesicles up to 15 µm in diameter, a
biseriate arrangement with crowded metulae and phialides, and small,
globose conidia (1.5 to 2.0 µm in diameter), all features
characteristic for A. terreus (Fig.
7). This atypical strain of A. terreus has been deposited with the American Type Culture
Collection under accession no. 201901. The isolate appeared to be
resistant to amphotericin B, ketoconazole, and fluconazole and to be
susceptible to itraconazole and flucytosine when tested on buffered
RPMI 1640 medium with Etest strips (AB Biodisk, Solna, Sweden), on the
basis of the National Committee for Clinical Laboratory Standards
interpretive criteria for yeast fungi (17).

View larger version (116K):
[in this window]
[in a new window]
|
FIG. 5.
Colony morphology of A. terreus isolate on
Mycobiotic agar after 7 days of incubation at 37°C.
|
|

View larger version (96K):
[in this window]
[in a new window]
|
FIG. 6.
Slide culture of A. terreus isolate on
Sabouraud dextrose agar showing globose, thick-walled accessory conidia
(aleurioconidia), Magnification, ×1,000.
|
|

View larger version (113K):
[in this window]
[in a new window]
|
FIG. 7.
Conidial head of the atypical isolate of A. terreus produced on PFA after 10 weeks of incubation at 25°C.
|
|
Discussion.
A. terreus is widespread in the environment
and particularly in warm arable soils. Although ubiquitous and
sometimes disregarded as a mere colonizer, a review of recent
English-language medical literature (Medline search) suggests that
invasive infections due to A. terreus are being reported
with increasing frequency (10; D. M. Flynn,
B. G. Williams, S. V. Hetherington, B. F. Williams,
M. A. Giannini, and T. A. Pearson, Letter, Infect. Control. Hosp. Epidemiol. 14:363-365, 1993). Furthermore, infection with this species may be associated with higher rates of morbidity and
mortality compared to those associated with infection with other
species of the genus, despite amphotericin B therapy (10, 14). Colonization of preexisting lung cavities with A. terreus has rarely been reported (12), and the case
that we describe appears to be only the second one reported in the
English-language medical literature. This case also underscores the
variability that may be seen in isolates of A. terreus. The
designations for several species have been reduced to synonyms under
the species as the organisms seem to represent only cultural variants.
The case isolate, on the basis of its colonial morphology, appears to
be similar to A. terreus var. boedijni, described
by Thom and Raper (29) (and since reduced), due to its
bright orange-brown colonies. It also resembles two currently accepted
varieties, A. terreus var. africanus and A. terreus var. aureus, in that it displays small,
sclerotial-like masses, as in A. terreus var. africanus, and areas of golden yellow hyphae and a much
greater abundance of accessory conidia both in the vegetative mycelium and in the aerial mycelium, as in A. terreus var.
aureus (18). Sterile variants of
Aspergillus have occasionally been isolated from patients
with chronic cases of aspergillosis; these variants sometimes appear
highly atypical and are difficult to identify (15;
L. Sigler, M. A. Viviani, U. Margini, R. Epis, V. Fregoni, A. Grancini, and A. Pastorini, Abstr. 13th Int. Soc. Hum. Anim. Mycol., p.
396, 1997). A sterile white mold which is able to grow at 45°C,
especially if it is isolated from a respiratory specimen, may be
suspected to be A. fumigatus because of its thermotolerant nature. However, to our knowledge sterile variants of A. terreus have not been reported previously. Application of the
exoantigen test may be helpful in the identification of such atypical
isolates (24).
Aspergilloma, a noninvasive form of aspergillosis, may develop in a
healthy host, in which the organism colonizes a cavity
that has been
created by some form of destructive process that
has previously
involved the lung, such as pulmonary tuberculosis,
as apparently is the
case with our patient (
1). In most of
the cases,
aspergilloma occurs singly on either side of the lung
field, but
bilateral involvement may be seen in about 5 to 10%
of the cases
(
5). Aspergilloma may even develop in areas of
bronchiectasis caused by allergic bronchopulmonary aspergillosis
(
26). Some recent reports, however, suggest that the
noninvasive
form of aspergillosis may not always be noninvasive
(
16). Instead
of developing in a preexisting cavity, it may
create its own cavity
and then grow as a relatively noninvasive
organism. This form
of infection has been termed semiinvasive
aspergillosis by Gefter
et al. (
8) and chronic necrotizing
aspergillosis by Binder
et al. (
2) and is not
distinguishable from noninvasive aspergillosis
(
16).
Semiinvasive aspergillosis tends to occur in patients
whose immune
systems are mildly depressed, for example, because
of chronic
obstructive lung disease or diabetes. Although our
patient had a
history of diabetes mellitus and had also had an
obstructive lung
function, it is impossible for us to document
the radiological
progression of the disease or clearly ascertain
whether it was a
classical form of aspergilloma or the consequence
of this newly
characterized form of semiinvasive aspergillosis.
The semiinvasive form
is known to start initially as an infiltrate
in one of the apices
which, over a period of weeks to months,
slowly develops cavitation
with formation of a "crescent sign."
Chang and King (
4)
described a case of invasive aspergillosis
caused by
A. terreus with an air-crescent sign in a leukemic
patient.
The classical radiological picture of aspergilloma is one of a mobile,
intracavitary mass usually in upper lobes, and the
mass is almost
pathognomonic of the disease (
1). However, aspergilloma
may
sometimes be difficult to see even if it is present, and CT
may be
necessary to show its presence (
21,
31). In our patient,
while the fungal ball was visible in the right upper lobe by chest
X
ray, it could also be seen on the left side by CT scan (Fig.
2). The
diagnosis of aspergilloma was confirmed by the presence
in serum of
precipitins against the patient's isolate. Although
the presence of
multiple precipitin bands is characteristic of
aspergilloma due to a
continuous antigenic stimulus in a generally
nonimmunocompromised host
(
1,
7), we found precipitins only
against culture filtrate
antigen. Occasionally, other intracavitary
masses, such as cancer or
Wegener's granulomatosis, may simulate
aspergilloma. However, a
negative precipitin test for
Aspergillus antigen can exclude
such a possibility. In our patient, initial
testing for precipitins
with
A. fumigatus,
A. flavus, and
Aspergillus (poly) antigens was negative until the serum was
tested against
the patient's isolate. This suggests that
A. terreus has little
or no cross-reactivity with
A. fumigatus or
A. flavus and that
a diagnosis may be
missed if homologous reagents are not used
(
12). The chances
of isolating
Aspergillus species from sputum
specimens in
patients with aspergilloma are about 50% (
1),
since it is
dependent upon the intrapulmonary location of the
lesion and its
communication to the bronchial tree. Demonstration
of precipitins
therefore has greater sensitivity and specificity
than culture for the
diagnosis of aspergilloma (
7,
19).
Aspergilloma of the respiratory tract is often a clinically occult
process until the patient complains of hemoptysis. It may
occasionally
be found during routine monitoring of patients with
cavitary
tuberculosis, as was the case with our patient. Specific
therapy is not
required for patients with asymptomatic aspergilloma
(
16).
However, it may be pertinent to mention here that our
A. terreus isolate was resistant to amphotericin B. This is
consistent
with reports of the increased resistance of clinical
isolates
of
A. terreus to amphotericin B (
14,
28; C. Lass-Florl, D.
Niederwieser, G. Kofler, and M. Dierich, Abstr. Focus on Fungal
Infections 6, abstr. 36, 1996).
Therefore, for patients for whom
treatment for
A. terreus
infection is warranted, use of itraconazole
or voriconazole could be a
better therapeutic option than use
of amphotericin B (
14,
28). The case described here is the
fourth case of aspergillosis
due to
A. terreus diagnosed by us
in Kuwait during the last
3 years; the other cases were of invasive
pulmonary aspergillosis (two
cases) and endocarditis. The report
underscores the increasing
importance of
A. terreus in the etiology
of pulmonary
aspergillosis.
 |
ACKNOWLEDGMENTS |
This work was supported by Kuwait University research grant MI 076.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology, Faculty of Medicine, Kuwait University, P.O. Box 24923, Kuwait 13110. Phone: (0965) 5312300. Fax: (0965) 5332719. E-mail: ziauddin{at}hsc.kuniv.edu.kw.
 |
REFERENCES |
| 1.
|
Albelda, S. M., and G. H. Talbot.
1988.
Pulmonary aspergillosis, p. 1639-1655.
In
A. P. Fishman (ed.), Pulmonary disease and disorders, 2nd ed. McGraw-Hill Book Co., New York, N.Y.
|
| 2.
|
Binder, R. E.,
L. J. Faling,
R. D. Pugatch,
C. Mahasaen, and G. L. Snider.
1982.
Chronic necrotizing pulmonary aspergillosis. A discrete clinical entity.
Medicine
61:109-118[Medline].
|
| 3.
|
Bodey, G. P., and S. Vartivarian.
1989.
Aspergillosis.
Eur. J. Clin. Microbiol. Infect. Dis.
8:413-437[CrossRef][Medline].
|
| 4.
|
Chang, S. W., and T. E. King.
1986.
Aspergillus terreus causing invasive pulmonary aspergillosis with air crescent sign.
J. Natl. Med. Assoc.
78:248-253[Medline].
|
| 5.
|
Chen, J. C.,
Y. L. Chang,
S. P. Luh,
J. M. Lee, and Y. C. Lee.
1997.
Surgical treatment for pulmonary aspergilloma: 28-year experience.
Thorax
52:810-813[Abstract].
|
| 6.
|
Chin, S.,
P. L. Ho,
S. T. Yuen, and K. Y. Yuen.
1998.
Fungal endocarditis in bone marrow transplantation: case report and review of literature.
J. Infect.
37:287-291[CrossRef][Medline].
|
| 7.
|
Evans, E. G. V. (ed.).
1976.
Serology of fungal infections and farmer's lung disease. A laboratory manual. British Society for Mycopathology Working Party.
British Society for Mycopathology, Leeds, United Kingdom.
|
| 8.
|
Gefter, W. B.,
T. R. Weingard,
D. M. Epstein,
R. H. Ochs, and W. T. Miller.
1981.
"Semi-invasive" pulmonary aspergillosis.
Radiology
140:313-321[Abstract/Free Full Text].
|
| 9.
|
Hara, K. S., and J. H. Ryce.
1989.
Disseminated Aspergillus terreus infection in immunocompromised hosts.
Mayo Clin. Proc.
64:770-775[Medline].
|
| 10.
|
Iwen, P. C.,
M. E. Rupp,
L. N. Langnas,
E. C. Reed, and S. H. Hinrichs.
1998.
Invasive pulmonary aspergillosis due to Aspergillus terreus: 12-year experience and review of literature.
Clin. Infect. Dis.
26:1092-1097[Medline].
|
| 11.
|
Khan, Z. U.,
R. S. Sandhu,
H. S. Randhawa,
M. P. S. Menon, and I. S. Dusaj.
1976.
Allergic bronchopulmonary aspergillosis: a study of 46 cases with special reference to laboratory aspects.
Scand. J. Respir. Dis.
57:73-87[Medline].
|
| 12.
|
Laham, M. N., and J. L. Carpenter.
1982.
Aspergillus terreus, a pathogen capable of causing infective endocarditis, pulmonary mycetoma and allergic bronchopulmonary aspergillosis.
Am. Rev. Respir. Dis.
125:769-772[Medline].
|
| 13.
|
Laham, M. N.,
R. C. Allen, and J. C. Greene.
1981.
Allergic bronchopulmonary aspergillosis (ABPA) caused by Aspergillus terreus-specific lymphocyte sensitization and antigen-directed serum opsonic activity.
Ann. Allergy
46:74-80[Medline].
|
| 14.
|
Lass-Florl, C.,
G. Kofler,
G. Kropshofer,
J. Hermans,
A. Kreczy,
M. P. Dierich, and D. Niederwieser.
1998.
In vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis.
J. Antimicrob. Chemother.
42:497-502[Abstract/Free Full Text].
|
| 15.
|
McGinnis, M. R.,
D. L. Buck, Jr., and B. Katz.
1997.
Paranasal aspergilloma caused by an albino variant of Aspergillus fumigatus.
South. Med. J.
70:886-888.
|
| 16.
|
Miller, W. T.
1996.
Aspergillosis: a disease with many faces.
Sem. Roentgenol.
31:52-66[Medline].
|
| 17.
|
National Committee for Clinical Laboratory Standards.
1997.
Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M 27-A.
National Committee for Clinical Laboratory Standards, Wayne, Pa.
|
| 18.
|
Raper, K. B., and D. I. Fennell.
1965.
The genus Aspergillus.
The Williams & Wilkins Co., Baltimore, Md.
|
| 19.
|
Rinaldi, M. G.
1988.
Aspergillosis, p. 559-572.
In
A. Balows, W. J. Hausler, Jr., M. Ohashi, and A. Turan (ed.), Laboratory diagnosis of infectious diseases. Principles and practice, vol. 1. Bacterial, mycotic and parasitic diseases. Springer-Verlag, New York, N.Y.
|
| 20.
|
Rinaldi, M. G.
1982.
Use of potato flake agar in clinical mycology.
J. Clin. Microbiol.
15:1159-1160[Abstract/Free Full Text].
|
| 21.
|
Roberts, G. M.,
K. M. Citron, and B. Stricteland.
1987.
Intrathoracic aspergilloma. Role of CT in diagnosis and treatment.
Radiology
165:123-128[Abstract/Free Full Text].
|
| 22.
|
Russack, V.
1990.
Aspergillus terreus myocarditis: report of a case and review of the literature.
Am. J. Cardiovasc. Pathol.
3:275-279[Medline].
|
| 23.
|
Schett, G.,
B. Casati,
B. Willinger,
G. Weinlander,
T. Binder,
F. Grabenwoger,
W. Sperr,
K. Geissler, and U. Jager.
1998.
Endocarditis and aortal embolization caused by Aspergillus terreus in a patient with acute lymphoblastic leukemia in remission diagnosis by peripheral blood culture.
J. Clin. Microbiol.
36:3347-3351[Abstract/Free Full Text].
|
| 24.
|
Sekhon, A. S.,
P. G. Standard,
L. Kaufman,
A. K. Garg, and P. Cifuentes.
1986.
Grouping of Aspergillus species with exoantigens.
Diagn. Immunol.
4:112-116[Medline].
|
| 25.
|
Seligsohn, R.,
J. W. Rippon, and S. A. Lerner.
1997.
Aspergillus terreus osteomyelitis.
Arch. Intern. Med.
137:918-920.
|
| 26.
|
Shah, A.,
Z. U. Khan,
S. Chaturvedi,
S. Ramachandaran,
H. S. Randhawa, and O. P. Jaggi.
1989.
Allergic bronchopulmonary aspergillosis with coexistent aspergilloma: a long-term follow-up.
J. Asthma
26:109-115[Medline].
|
| 27.
|
Steinfield, S.,
P. Durez,
J. P. Hauzeur,
S. Motte, and T. Appelboom.
1997.
Articular aspergillosis. Two case reports and review of the literature.
Br. J. Rheumatol.
36:1331-1334[Abstract/Free Full Text].
|
| 28.
|
Sutton, D. A.,
S. E. Sanche,
S. G. Revankar,
A. W. Fothergill, and M. G. Rinaldi.
1999.
In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole.
J. Clin. Microbiol.
37:2243-2245.
|
| 30.
|
Thom, C., and K. B. Raper.
1945.
Manual of aspergilli.
The Williams & Wilkins Co., Baltimore, Md.
|
| 31.
|
Tritz, D. W., and G. L. Woods.
1993.
Fatal disseminated infection with Aspergillus terreus in immunocompromised hosts.
Clin. Infect. Dis.
16:118-122[Medline].
|
| 32.
|
Zimmerman, R. A., and W. T. Miller.
1970.
Pulmonary aspergillosis.
Am. J. Roentgenol. Radium Ther. Nucl. Med.
109:505-515[Medline].
|
Journal of Clinical Microbiology, May 2000, p. 2010-2014, Vol. 38, No. 5
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Steinbach, W. J., Perfect, J. R., Schell, W. A., Walsh, T. J., Benjamin, D. K. Jr.
(2004). In Vitro Analyses, Animal Models, and 60 Clinical Cases of Invasive Aspergillus terreus Infection. Antimicrob. Agents Chemother.
48: 3217-3225
[Full Text]
-
Pepeljnjak, S, Slobodnjak, Z, Segvic, M, Peraica, M, Pavlovic, M
(2004). The ability of fungal isolates from human lung aspergilloma to produce mycotoxins. Hum Exp Toxicol
23: 15-19
[Abstract]
-
Espinel-Ingroff, A., Bartlett, M., Chaturvedi, V., Ghannoum, M., Hazen, K. C., Pfaller, M. A., Rinaldi, M., Walsh, T. J.
(2001). Optimal Susceptibility Testing Conditions for Detection of Azole Resistance in Aspergillus spp.: NCCLS Collaborative Evaluation. Antimicrob. Agents Chemother.
45: 1828-1835
[Abstract]
[Full Text]